Healthcare -
Biotechnology - NASDAQ - US
$ 46.86
-4.01 %
$ 2.02 B
Market Cap
-10.7
P/E
SLNO - STOCK-BASED COMPENSATION
Stock-based Compensation SLNO - Soleno Therapeutics, Inc.
5.94 M
LAST VALUE
34.71%
2 YEAR CAGR
43.18%
5 YEAR CAGR
65.56%
10 YEAR CAGR